Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 456
Immune Disorders Drugs 193
Cardiovascular Drugs 157
Drug Discovery 148
Infectious Diseases Drugs 132
Biopharmaceuticals 127
Endocrine and Metabolic Disorders Drugs 111
Clinical Trials 107
Central Nervous System Drugs 105
Musculoskeletal Disorders Drugs 96
Pharmaceuticals 95
Leukemia Drugs 80
Hematological Drugs 77
Liver and Kidney Disorders Drugs 75
Lymphoma Drugs 62
Diabetes Drugs 57
Dermatological Drugs 57
Skin Cancer Drugs 48
Brain Cancer Drugs 46
Respiratory Drugs 45
Mental Disorders Drugs 43
Lung Cancer Drugs 39
Gastrointestinal Drugs 38
Pharmaceutical Intermediates 34
Drug Delivery 34
Immunosuppressive Drugs 33
Pharmaceutical Manufacturing 31
Infusions and Injectables 30
Liver Cancer Drugs 29
Analgesics 27
Antibiotics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 21
Pancreatic Cancer Drugs 19
Prostate Cancer Drugs 18
Urological Disorders Drugs 18
Colon Cancer Drugs 17
HIV/AIDS Drugs 17
Schizophrenia Drugs 17
Cervical Cancer Drugs 16
Sexual and Reproductive Health Drugs 16
Ovarian Cancer Drugs 15
Thyroid Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Psoriasis Drugs 12
Over the Counter (OTC) Drugs 11
Biosimilars and Biosuperiors 11
Generic Drugs 10
Anti-Obesity Drugs 9
Optical Disorders Drugs 8
Vaccines 8
Transdermal and Transmucosal Drug Delivery 7
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Cough and Cold Drugs 5
Anxiety Drugs 4
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Asthma Drugs 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Allergy Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



278 reviews

2,403 Results (Page 58 of 121)
- Relevance
  Sort by

North America Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Oral, Intravenous and Topical), By Drug Class, By Country and Growth Forecast, 2022 - 2028

 Report
November 2022
71 Pages
North America

From

€1324EUR$1,500USD£1,148GBP

Multiple Myeloma- Pipeline Insight, 2025

 Clinical Trials
April 2025
230 Pages
Global

From

€2649EUR$3,000USD£2,296GBP

Diffuse Large B-cell Lymphoma Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
March 2025
183 Pages
Global

From

€3973EUR$4,500USD£3,444GBP

Polycystic Ovarian Syndrome Treatment Market by Treatment Type, Drug Class, Route Of Administration, Distribution Channel, End User, Patient Type - Global Forecast 2025-2030

 Report
August 2025
188 Pages
Global

From

€3130EUR$3,545USD£2,713GBP

€3478EUR$3,939USD£3,015GBP

Non-Hodgkin Lymphoma Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
112 Pages
Global

From

€4194EUR$4,750USD£3,635GBP

NEED HELP FINDING THE RIGHT PRODUCT? Francesca will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

T-Cell Lymphoma - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
132 Pages
Global

From

€4194EUR$4,750USD£3,635GBP

Leukemia Therapeutics Market Analysis & Forecast to 2024-2034

 Report
January 2024
200 Pages
Global

From

€3664EUR$4,150USD£3,176GBP

Hairy Cell Leukemia Market Analysis & Forecast to 2024-2034

 Report
January 2024
200 Pages
Global

From

€3664EUR$4,150USD£3,176GBP

Lysophosphatidic Acid Receptor 1 (Lysophosphatidic Acid Receptor Edg 2 or LPAR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
July 2022
38 Pages
Global

From

€3090EUR$3,500USD£2,679GBP

Dilated Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
February 2022
80 Pages
Global

From

€1766EUR$2,000USD£1,531GBP

Sexually Transmitted Diseases (STD) Treatment Market 2025-2029

 Report
July 2025
220 Pages
Global

From

€2207EUR$2,500USD£1,913GBP

Diffuse Large B-Cell Lymphoma - Pipeline Insight, 2025

 Clinical Trials
April 2025
240 Pages
Global

From

€2649EUR$3,000USD£2,296GBP

Influenza Medication Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

 Report
May 2022
92 Pages
Global

From

€3500EUR$4,246USD£3,140GBP

Ewing Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
204 Pages
Global

From

€1766EUR$2,000USD£1,531GBP

Kaposi Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
94 Pages
Global

From

€1766EUR$2,000USD£1,531GBP

Gallbladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
195 Pages
Global

From

€1766EUR$2,000USD£1,531GBP

Parkinson's Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
September 2022
1079 Pages
Global

From

€2207EUR$2,500USD£1,913GBP

B-cell Lymphoma- Pipeline Insight, 2025

 Clinical Trials
April 2025
450 Pages
Global

From

€4415EUR$5,000USD£3,827GBP

Follicular Lymphoma - Pipeline Insight, 2025

 Clinical Trials
April 2025
150 Pages
Global

From

€2207EUR$2,500USD£1,913GBP

Nasopharyngeal Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

 Report
July 2022
521 Pages
Global

From

€2207EUR$2,500USD£1,913GBP

2,403 Results (Page 58 of 121)
- 1
- 56
- 57
- 58
- 59
- 60

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.